FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Steven Allen

Research Profile

Disorders

B-Cell Chronic Lymphocytic Leukemia

Procedures

Chemicals & Drugs

Anatomy

Physiology

Mutation

Concepts & Ideas

Genes & Molecular Sequences

Genes, Immunoglobulin

Co-author Network

Publications

TOP 3
Piers E M Patten; Kanti R Rai; Sergio Roa; Matthew D Scharff; Joy (Xiao-Jie) Yan; Lu Zhang; Emilia Albesiano; Steven Allen; Jacqueline Barrientos; Charles C Chu; Rajendra N Damle; Dorothy Kim; Jonathan E Kolitz; Thomas MacCarthy; Amanda R Magli; Patricia K Mongini; Nicholas Chiorazzi
IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functions.
M J Lanctot; Steven Allen; M E Fenstermacher; CT Holcomb; T C Luce
Pedestal magnetic field measurements using a motional Stark effect polarimeter.
T R Weber; Steven Allen; J Howard
C-III flow measurements with a coherence imaging spectrometer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Steven Allen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Piers E M Patten; Kanti R Rai; Sergio Roa; Matthew D Scharff; Joy (Xiao-Jie) Yan; Lu Zhang; Emilia Albesiano; Steven Allen; Jacqueline Barrientos; Charles C Chu; Rajendra N Damle; Dorothy Kim; Jonathan E Kolitz; Thomas MacCarthy; Amanda R Magli; Patricia K Mongini; Nicholas Chiorazzi
IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functions.
Blood 2012;120(24):4802-11.
2012: M J Lanctot; Steven Allen; M E Fenstermacher; CT Holcomb; T C Luce
Pedestal magnetic field measurements using a motional Stark effect polarimeter.
The Review of scientific instruments 2012;83(10):10E319.
2012: T R Weber; Steven Allen; J Howard
C-III flow measurements with a coherence imaging spectrometer.
The Review of scientific instruments 2012;83(10):10E102.
2012: Rajendra N Damle; Jonathan E Kolitz; Patricia K A Mongini; Santanu Paul; Kanti R Rai; Sonal Temburni; Steven Allen; Taraneh Banapour; Nicholas Chiorazzi
T-cell independent, B-cell receptor-mediated induction of telomerase activity differs among IGHV mutation-based subgroups of chronic lymphocytic leukemia patients.
Blood 2012;120(12):2438-49.
2011: Richard L Piekarz; Robin Frye; H Miles Prince; Mark H Kirschbaum; Jasmine Zain; Steven Allen; Elaine S Jaffe; Alexander Ling; Maria Turner; Cody J Peer; William D Figg; Seth M Steinberg; Sonali Smith; David Joske; Ian Lewis; Laura Hutchins; Michael Craig; Antonio Tito Fojo; John J Wright; Susan E Bates
Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma.
Blood 2011;117(22):5827-34.
2011: Davide Bagnara; Matthew Kaufman; Carlo Calissano; Sonia Marsilio; Piers E M Patten; Rita Simone; Philip Chum; Joy (Xiao-Jie) Yan; Steven Allen; Jonathan E Kolitz; Sivasubramanian Baskar; Christoph Rader; Hakan Mellstedt; Hodjattallah Rabbani; Annette Lee; Peter K Gregersen; Kanti R Rai; Nicholas Chiorazzi
A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease.
Blood 2011;117(20):5463-72.
2011: J D King; MA Makowski; CT Holcomb; Steven Allen; DN Hill; R J La Haye; F Turco; C C Petty; M A Van Zeeland; TL Rhodes; W H Meyer; R Geer; E C Morse
Magnetohydrodynamic interference with the edge pedestal motional Stark effect diagnostic on DIII-D.
The Review of scientific instruments 2011;82(3):033515.
2011: Dmitry Nurminsky; Shobana Shanmugasundaram; Stephanie Deasey; Claire Michaud; Steven Allen; Doris Hendig; Akbar Dastjerdi; Philippa Francis-West; Maria Nurminskaya
Transglutaminase 2 regulates early chondrogenesis and glycosaminoglycan synthesis.
Mechanisms of development 2011;128(3-4):234-45.
2011: Carlo Calissano; Steven Allen; Rajendra N Damle; Igor M Dozmorov; Claire Emson; Gregory Hayes; Marc K Hellerstein; Ivana Ivanovic; Matthew Kaufman; Jonathan E Kolitz; Wentian Li; Sonia Marsilio; Elizabeth J Murphy; Kanti R Rai; Sergio Roa; Matthew D Scharff; Cristina Sison; Joy (Xiao-Jie) Yan; Sophia Yancopoulos; Nicholas Chiorazzi
Intraclonal complexity in chronic lymphocytic leukemia: fractions enriched in recently born/divided and older/quiescent cells.
Molecular medicine (Cambridge, Mass.) 2011;17(11-12):1374-82.
2011: Charles C Chu; Rajendra N Damle; Arjun Dhayalan; Sebastien Didier; Gia Fraher; Linda P Johnson; William J Kennedy; Prasad R K Koduru; Jonathan E Kolitz; Amanda R Magli; Piers E M Patten; Kanti R Rai; Saul Teichberg; Joy (Xiao-Jie) Yan; Lu Zhang; Briana M Agagnina; Steven Allen; Nicholas Chiorazzi
Torque teno virus 10 isolated by genome amplification techniques from a patient with concomitant chronic lymphocytic leukemia and polycythemia vera.
Molecular medicine (Cambridge, Mass.) 2011;17(11-12):1338-48.
2010: Jonathan E Kolitz; Stephen L George; Guido Marcucci; Ravi Vij; Bayard L Powell; Steven Allen; Daniel J DeAngelo; Thomas C Shea; Wendy Stock; Maria R Baer; Vera Hars; Kati Maharry; Eva Hoke; James W Vardiman; Clara D Bloomfield; Richard A Larson
P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808.
Blood 2010;116(9):1413-21.
2010: Laura L Donahue; Iuliana Shapira; Aryeh Shander; Jonathan Kolitz; Steven Allen; Gerson Greenburg
Management of acute anemia in a Jehovah's Witness patient with acute lymphoblastic leukemia with polymerized bovine hemoglobin-based oxygen carrier: a case report and review of literature.
Transfusion 2010;50(7):1561-7.
2010: Charles C Chu; Rosa Catera; Lu Zhang; Sebastien Didier; Briana M Agagnina; Rajendra N Damle; Matthew Kaufman; Jonathan E Kolitz; Steven Allen; Kanti Rai; Nicholas Chiorazzi
Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin.
Blood 2010;115(19):3907-15.
2010: Kit L Cheng; Judith Brody; Craig Warshall; Elaine M Sloand; Steven Allen
Paroxysmal nocturnal hemoglobinuria following alemtuzumab immunosuppressive therapy for myelodysplastic syndrome and complicated by recurrent life-threatening thrombosis despite anticoagulation: successful intervention with eculizumab and fondaparinux.
Leukemia research 2010;34(4):e85-7.
2010: Steven Allen; Jonathan E Kolitz; Ante S Lundberg; John M Bennett; Robert L Capizzi; Daniel R Budman
Phase I trials of amonafide as monotherapy and in combination with cytarabine in patients with poor-risk acute myeloid leukemia.
Leukemia research 2010;34(4):487-91.
2009: Carlo Calissano; Rajendra N Damle; Gregory Hayes; Elizabeth J Murphy; Marc K Hellerstein; Carol Moreno; Cristina Sison; Matthew Kaufman; Jonathan E Kolitz; Steven Allen; Kanti Rai; Nicholas Chiorazzi
In vivo intraclonal and interclonal kinetic heterogeneity in B-cell chronic lymphocytic leukemia.
Blood 2009;114(23):4832-42.
2009: Richard L Piekarz; Robin Frye; Maria Turner; John J Wright; Steven Allen; Mark H Kirschbaum; Jasmine Zain; H Miles Prince; John P Leonard; Larisa J Geskin; Craig Reeder; David Joske; William D Figg; Erin R Gardner; Seth M Steinberg; Elaine S Jaffe; Maryalice Stetler-Stevenson; Stephen Lade; A Tito Fojo; Susan E Bates
Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(32):5410-7.
2009: Till Seiler; Manuela Woelfle; Sophia Yancopoulos; Rosa Catera; Wentian Li; Katerina Hatzi; Carol Moreno; Marcela Torres; Santanu Paul; Hartmut Dohner; Stephan Stilgenbauer; Matthew Kaufman; Jonathan E Kolitz; Steven Allen; Kanti Rai; Charles C Chu; Nicholas Chiorazzi
Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cells.
Blood 2009;114(17):3615-24.
2009: Vladimir Grubor; Alexander Krasnitz; Jennifer E Troge; Jennifer L Meth; B Lakshmi; Jude T Kendall; Boris Yamrom; Garrick Alex; Deepa Pai; Nicholas Navin; Lisa A Hufnagel; Yoon-Ha Lee; Kerry Cook; Steven Allen; Kanti Rai; Rajendra N Damle; Carlo Calissano; Nicholas Chiorazzi; Michael Wigler; Diane Esposito
Novel genomic alterations and clonal evolution in chronic lymphocytic leukemia revealed by representational oligonucleotide microarray analysis (ROMA).
Blood 2009;113(6):1294-303.
2008: Charles C Chu; Rosa Catera; Katerina Hatzi; Joy (Xiao-Jie) Yan; Lu Zhang; Xiao Bo Wang; Henry M Fales; Steven Allen; Jonathan E Kolitz; Kanti Rai; Nicholas Chiorazzi
Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA.
Blood 2008;112(13):5122-9.
2008: Rosa Catera; Gregg J Silverman; Katerina Hatzi; Till Seiler; Sebastien Didier; Lu Zhang; Maxime Hervé; Eric Meffre; David G Oscier; Helen Vlassara; R Hal Scofield; Yifang Chen; Steven Allen; Jonathan Kolitz; Kanti Rai; Charles C Chu; Nicholas Chiorazzi
Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidation.
Molecular medicine (Cambridge, Mass.) 2008;14(11-12):665-74.
2008: Brian A McCarthy; Erin Boyle; Xue Ping Wang; Dorothy Guzowski; Santanu Paul; Rosa Catera; Joshua Trott; Joy (Xiao-Jie) Yan; Carlo M Croce; Rajendra N Damle; Sophia Yancopoulos; Bradley T Messmer; Martin Lesser; Steven Allen; Kanti Rai; Nicholas Chiorazzi
Surface expression of Bcl-2 in chronic lymphocytic leukemia and other B-cell leukemias and lymphomas without a breakpoint t(14;18).
Molecular medicine (Cambridge, Mass.) 2008;14(9-10):618-27.
2008: Anthony Calabro; Julia Tai; Steven Allen; Daniel R Budman
In-vitro synergism of m-TOR inhibitors, statins, and classical chemotherapy: potential implications in acute leukemia.
Anti-cancer drugs 2008;19(7):705-12.
2008: M F Barginear; L Donahue; Steven Allen; Daniel R Budman; Thomas Bradley; M Bhaskaran; Iuliana Shapira
Heparin-induced thrombocytopenia complicating hemodialysis.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2008;14(1):105-7.
2007: Rajendra N Damle; Sonal Temburni; Carlo Calissano; Sophia Yancopoulos; Taraneh Banapour; Cristina P Sison; Steven Allen; Kanti Rai; Nicholas Chiorazzi
CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells.
Blood 2007;110(9):3352-9.
2007: Samit Hirawat; Jonathan E Kolitz; Stuart M Lichtman; Steven Allen; Gina Villani; Alma Gonzales; Marjorie Fricano; Daniel R Budman
A Phase I dose-finding study using an innovative sequential biweekly schedule of irinotecan followed 24 hours later by capecitabine.
Cancer investigation 2007;25(3):148-53.
2006: Fabio Ghiotto; Franco Fais; Emilia Albesiano; Cristina P Sison; Angelo Valetto; Gianluca Gaidano; Janine Reinhardt; Jonathan E Kolitz; Kanti Rai; Steven Allen; Manlio Ferrarini; Nicholas Chiorazzi
Similarities and differences between the light and heavy chain Ig variable region gene repertoires in chronic lymphocytic leukemia.
Molecular medicine (Cambridge, Mass.) 2006;12(11-12):300-8.
2006: Lin Li; Shiphali Gupta; Tayyaba Bashir; Prasad R K Koduru; Judith Brody; Steven Allen
Serial cytogenetic alterations resulting in transformation of a low-grade follicular lymphoma to Burkitt lymphoma.
Cancer genetics and cytogenetics 2006;170(2):140-6.
2005: Francis H Grand; Prasad R K Koduru; Nicholas C P Cross; Steven Allen
NUP98-LEDGF fusion and t(9;11) in transformed chronic myeloid leukemia.
Leukemia research 2005;29(12):1469-72.
2005: Bradley T Messmer; Davorka Messmer; Steven Allen; Jonathan E Kolitz; Prasad Kudalkar; Denise Cesar; Elizabeth J Murphy; Prasad R K Koduru; Manlio Ferrarini; Simona Zupo; Giovanna Cutrona; Rajendra N Damle; Tarun Wasil; Kanti Rai; Marc K Hellerstein; Nicholas Chiorazzi
In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells.
The Journal of clinical investigation 2005;115(3):755-64.
2005: Nicholas Chiorazzi; Steven Allen; Manlio Ferrarini
Clinical and laboratory parameters that define clinically relevant B-CLL subgroups.
Current topics in microbiology and immunology 2005;294():109-33.
2004: Jonathan E Kolitz; Stephen L George; Richard K Dodge; David D Hurd; Bayard L Powell; Steven Allen; Enrique Velez-Garcia; Joseph O Moore; Thomas C Shea; Eva Hoke; Michael A Caligiuri; James W Vardiman; Clara D Bloomfield; Richard A Larson
Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Group B Study 9621.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(21):4290-301.
2004: Bradley T Messmer; Emilia Albesiano; Dimitar G Efremov; Fabio Ghiotto; Steven Allen; Jonathan E Kolitz; Robin Foa; Rajendra N Damle; Franco Fais; Davorka Messmer; Kanti Rai; Manlio Ferrarini; Nicholas Chiorazzi
Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia.
The Journal of experimental medicine 2004;200(4):519-25.
2004: Davorka Messmer; Gloria Telusma; Tarun Wasil; Bradley T Messmer; Steven Allen; Kanti Rai; Nicholas Chiorazzi
Dendritic cells from chronic lymphocytic leukemia patients are normal regardless of Ig V gene mutation status.
Molecular medicine (Cambridge, Mass.) 2004;10(7-12):96-103.
2004: Fabio Ghiotto; Franco Fais; Angelo Valetto; Emilia Albesiano; Shiori Hashimoto; Mariella Dono; Hideyuki Ikematsu; Steven Allen; Jonathan E Kolitz; Kanti Rai; Marco Nardini; Anna Tramontano; Manlio Ferrarini; Nicholas Chiorazzi
Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia.
The Journal of clinical investigation 2004;113(7):1008-16.
2004: James D Hoyer; Steven Allen; Ernest Beutler; Kathleen S Kubik; Carol West; Virgil F Fairbanks
Erythrocytosis due to bisphosphoglycerate mutase deficiency with concurrent glucose-6-phosphate dehydrogenase (G-6-PD) deficiency.
American journal of hematology 2004;75(4):205-8.
2004: Rajendra N Damle; Franak M Batliwalla; Fabio Ghiotto; Angelo Valetto; Emilia Albesiano; Cristina P Sison; Steven Allen; Jonathan E Kolitz; Vincent P Vinciguerra; Prasad Kudalkar; Tarun Wasil; Kanti Rai; Manlio Ferrarini; Peter K Gregersen; Nicholas Chiorazzi
Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations.
Blood 2004;103(2):375-82.
2003: Emilia Albesiano; Bradley T Messmer; Rajendra N Damle; Steven Allen; Kanti Rai; Nicholas Chiorazzi
Activation-induced cytidine deaminase in chronic lymphocytic leukemia B cells: expression as multiple forms in a dynamic, variably sized fraction of the clone.
Blood 2003;102(9):3333-9.
2003: Claudia D Baldus; Stephan M Tanner; Amy S Ruppert; Susan P Whitman; Kellie J Archer; Guido Marcucci; Michael A Caligiuri; Andrew J Carroll; James W Vardiman; Bayard L Powell; Steven Allen; Joseph O Moore; Richard A Larson; Jonathan E Kolitz; Albert de La Chapelle; Clara D Bloomfield
BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study.
Blood 2003;102(5):1613-8.
2003: Howard L Parnes; Constance Cirrincione; Joseph Aisner; Donald A Berry; Steven Allen; Jeffrey Abrams; E Chuang; M Robert Cooper; Michael C Perry; David B Duggan; T P Szatrowski; I Craig Henderson; Larry Norton
Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(9):1819-24.
2003: Michael J Keating; Nicholas Chiorazzi; Bradley T Messmer; Rajendra N Damle; Steven Allen; Kanti Rai; Manlio Ferrarini; Thomas Kipps
Biology and treatment of chronic lymphocytic leukemia.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2003;():153-75.
2002: Carmela Gurrieri; Peter McGuire; Hong Zan; Joy (Xiao-Jie) Yan; Andrea Cerutti; Emilia Albesiano; Steven Allen; Vincent P Vinciguerra; Kanti Rai; Manlio Ferrarini; Paolo Casali; Nicholas Chiorazzi
Chronic lymphocytic leukemia B cells can undergo somatic hypermutation and intraclonal immunoglobulin V(H)DJ(H) gene diversification.
The Journal of experimental medicine 2002;196(5):629-39.
2002: Rajendra N Damle; Fabio Ghiotto; Angelo Valetto; Emilia Albesiano; Franco Fais; Joy (Xiao-Jie) Yan; Cristina P Sison; Steven Allen; Jonathan E Kolitz; Philip Schulman; Vincent P Vinciguerra; Petra Budde; Jurgen Frey; Kanti Rai; Manlio Ferrarini; Nicholas Chiorazzi
B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes.
Blood 2002;99(11):4087-93.
2002: Farbod Darvishian; Samit Hirawat; Saul Teichberg; David Wolk; Steven Allen; Steven I Hajdu
Langerhans' cell histiocytosis in the parotid gland.
Annals of clinical and laboratory science 2002;32(2):201-6.
2001: A Demiroglu; E J Steer; C Heath; Kerry Taylor; Mark Bentley; Steven Allen; Prasad R K Koduru; JP Brody; G Hawson; Robyn Rodwell; M L Doody; F Carnicero; A Reiter; John M Goldman; Junia V Melo; Nicholas C P Cross
The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins.
Blood 2001;98(13):3778-83.
2001: Stuart M Lichtman; Jonathan E Kolitz; Daniel R Budman; Philip Schulman; Vincent P Vinciguerra; Mark Hoffman; A Mittelman; Steven Allen; D Fusco; F A Hayes
Treatment of aggressive non-Hodgkin's lymphoma in elderly patients with thiotepa, Novantrone (mitoxantrone), vincristine, prednisone (TNOP).
American journal of clinical oncology 2001;24(4):360-2.
2001: Daniel R Budman; R Johnson; B Barile; R R Bowsher; Vincent P Vinciguerra; Steven Allen; Jonathan E Kolitz; C S Ernest; Willi Kreis; P Zervos; J Walling
Phase I and pharmacokinetic study of LY309887: a specific inhibitor of purine biosynthesis.
Cancer chemotherapy and pharmacology 2001;47(6):525-31.
2001: Samit Hirawat; Stuart M Lichtman; Steven Allen
Recombinant human erythropoietin use in hemolytic anemia due to prosthetic heart valves: a promising treatment.
American journal of hematology 2001;66(3):224-6.
2000: Rajendra N Damle; Franco Fais; Fabio Ghiotto; Angelo Valetto; Emilia Albesiano; Tarun Wasil; Franak M Batliwalla; Steven Allen; Philip Schulman; Vincent P Vinciguerra; Kanti Rai; Peter K Gregersen; Manlio Ferrarini; Nicholas Chiorazzi
Chronic lymphocytic leukemia: a proliferation of B cells at two distinct stages of differentiation.
Current topics in microbiology and immunology 2000;252():285-92.
1999: Rajendra N Damle; Tarun Wasil; Franco Fais; Fabio Ghiotto; Angelo Valetto; Steven Allen; A Buchbinder; Daniel R Budman; K Dittmar; Jonathan E Kolitz; Stuart M Lichtman; Philip Schulman; Vincent P Vinciguerra; Kanti Rai; Manlio Ferrarini; Nicholas Chiorazzi
Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.
Blood 1999;94(6):1840-7.
1999: R L Bayer; Stuart M Lichtman; Steven Allen; Daniel R Budman; A Buchbinder; J Fetten; Jonathan E Kolitz; Joseph Loscalzo
Acquired factor VIII inhibitors--successful treatment with an oral outpatient regimen.
American journal of hematology 1999;60(1):70-1.
1998: Franco Fais; Fabio Ghiotto; S Hashimoto; B Sellars; Angelo Valetto; Steven Allen; Philip Schulman; Vincent P Vinciguerra; Kanti Rai; Laura Rassenti; Thomas Kipps; Guillaume Dighiero; Harry Schroeder; Manlio Ferrarini; Nicholas Chiorazzi
Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors.
The Journal of clinical investigation 1998;102(8):1515-25.
1998: Edward J Lee; Stephen L George; Philip C Amrein; P A Paciucci; Steven Allen; Charles Alan Schiffer
An evaluation of combinations of diaziquone, etoposide and mitoxantrone in the treatment of adults with relapsed or refractory acute myeloid leukemia: results of 8722, a randomized phase II study conducted by Cancer and Leukemia Group B.
Leukemia 1998;12(2):139-43.
1997: D Serrano; J Monteiro; Steven Allen; Jonathan E Kolitz; Philip Schulman; Stuart M Lichtman; A Buchbinder; Vincent P Vinciguerra; Nicholas Chiorazzi; Peter K Gregersen
Clonal expansion within the CD4+CD57+ and CD8+CD57+ T cell subsets in chronic lymphocytic leukemia.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(3):1482-9.
1996: Franco Fais; B Sellars; Fabio Ghiotto; Joy (Xiao-Jie) Yan; Mariella Dono; Steven Allen; Daniel R Budman; K Dittmar; Jonathan E Kolitz; Stuart M Lichtman; Philip Schulman; M Schuster; Vincent P Vinciguerra; Kanti Rai; F K Stevenson; Peter K Gregersen; Manlio Ferrarini; Nicholas Chiorazzi
Examples of in vivo isotype class switching in IgM+ chronic lymphocytic leukemia B cells.
The Journal of clinical investigation 1996;98(7):1659-66.
1996: M Soni; J Brody; Steven Allen; Philip Schulman; Jonathan E Kolitz; Kanti Rai; J D Broome; Prasad R K Koduru
Clinical and morphological features of cases of trisomy 13 in acute non-lymphocytic leukemia.
Leukemia 1996;10(4):619-23.
1996: Mariella Dono; S Hashimoto; Franco Fais; V Trejo; Steven Allen; Stuart M Lichtman; Philip Schulman; Vincent P Vinciguerra; B Sellars; Peter K Gregersen; Manlio Ferrarini; Nicholas Chiorazzi
Evidence for progenitors of chronic lymphocytic leukemia B cells that undergo intraclonal differentiation and diversification.
Blood 1996;87(4):1586-94.
1996: Steven Allen; L P Schacter; Stuart M Lichtman; R Bukowski; D Fusco; Martee Hensley; P O'Dwyer; A Mittelman; B Rosenbloom; S Huybensz
Phase II study of elsamitrucin (BMY-28090) for the treatment of patients with refractory/relapsed non-Hodgkin's lymphoma.
Investigational new drugs 1996;14(2):213-7.
1996: W Kreis; K Chan; Daniel R Budman; Steven Allen; D Fusco; A Mittelman; K Hock; S Akerman; A Calabro; C Puccio; M Spigelman
Clinical pharmacokinetics of amonafide (NSC 308847) in 62 patients.
Cancer investigation 1996;14(4):320-7.
1995: parkash Gill; W Harrington; Mark H Kaplan; R C Ribeiro; J M Bennett; Howard A Liebman; M Bernstein-Singer; Byron M Espina; Lisa Cabral; Steven Allen
Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine.
The New England journal of medicine 1995;332(26):1744-8.
1995: J P Brody; Steven Allen; Philip Schulman; Tsieh Sun; W C Chan; H D Friedman; S Teichberg; Prasad R K Koduru; R W Cone; T P Loughran
Acute agranular CD4-positive natural killer cell leukemia. Comprehensive clinicopathologic studies including virologic and in vitro culture with inducing agents.
Cancer 1995;75(10):2474-83.
1995: S Hashimoto; Mariella Dono; M Wakai; Steven Allen; Stuart M Lichtman; Philip Schulman; Vincent P Vinciguerra; Manlio Ferrarini; Jack Silver; Nicholas Chiorazzi
Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells.
The Journal of experimental medicine 1995;181(4):1507-17.
1995: Florencia Bullrich; TK MacLachlan; Nianli Sang; Teresa Druck; Maria L Veronese; Steven Allen; Nicholas Chiorazzi; Andrew Koff; K Heubner; Carlo M Croce
Chromosomal mapping of members of the cdc2 family of protein kinases, cdk3, cdk6, PISSLRE, and PITALRE, and a cdk inhibitor, p27Kip1, to regions involved in human cancer.
Cancer research 1995;55(6):1199-205.
1994: Daniel R Budman; L N Igwemezie; S Kaul; J Behr; Stuart M Lichtman; Philip Schulman; Vincent P Vinciguerra; Steven Allen; Jonathan E Kolitz; K Hock
Phase I evaluation of a water-soluble etoposide prodrug, etoposide phosphate, given as a 5-minute infusion on days 1, 3, and 5 in patients with solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(9):1902-9.
1994: Raymond B Weiss; B L Peterson; Steven Allen; S M Browning; D B Duggan; Charles Alan Schiffer
A phase II trial of didemnin B in myeloma. A Cancer and Leukemia Group B (CALGB) study.
Investigational new drugs 1994;12(1):41-3.
1994: M Wakai; S Hashimoto; M Omata; Z M Sthoeger; Steven Allen; Stuart M Lichtman; Philip Schulman; Vincent P Vinciguerra; Betty Diamond; Mariella Dono
IgG+, CD5+ human chronic lymphocytic leukemia B cells. Production of IgG antibodies that exhibit diminished autoreactivity and IgG subclass skewing.
Autoimmunity 1994;19(1):39-48.
1993: J H Marsh; Willi Kreis; B Barile; S Akerman; Philip Schulman; Steven Allen; L C DeMarco; M W Schuster; Daniel R Budman
Therapy of refractory/relapsed acute myeloid leukemia and blast crisis of chronic myeloid leukemia with the combination of cytosine arabinoside, tetrahydrouridine, and carboplatin.
Cancer chemotherapy and pharmacology 1993;31(6):481-4.
1992: R V Spera; Mark H Kaplan; Steven Allen
Clostridium sordellii bacteremia: case report and review.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1992;15(6):950-4.
1992: Stuart M Lichtman; M Buchholtz; J Marino; Philip Schulman; Steven Allen; L Weiselberg; Daniel R Budman; L DeMarco; M Schuster; J Lovecchio
Use of cisplatin for elderly patients.
Age and ageing 1992;21(3):202-4.
1991: Willi Kreis; Daniel R Budman; K Chan; Steven Allen; Philip Schulman; Stuart M Lichtman; L Weiselberg; M Schuster; J Freeman; S Akerman
Therapy of refractory/relapsed acute leukemia with cytosine arabinoside plus tetrahydrouridine (an inhibitor of cytidine deaminase)--a pilot study.
Leukemia 1991;5(11):991-8.
1991: Stuart M Lichtman; Daniel R Budman; H Bosworth; Steven Allen; Philip Schulman; L Weiselberg; R Weiss; D Lehrman; Vincent P Vinciguerra
Adjuvant therapy of stage II breast cancer treated with CMFVP, radiation therapy and VATH following lumpectomy. A pilot trial.
American journal of clinical oncology 1991;14(4):317-21.
1991: H L Parnes; J S Abrams; N Tait; J Minford; Steven Allen; D Duggan; Joseph Aisner
Phase I/II study of cyclophosphamide, doxorubicin, fluorouracil, and leucovorin for treatment of metastatic adenocarcinoma.
Journal of the National Cancer Institute 1991;83(14):1017-20.
1991: H Ahuja; M Bar-Eli; Z Arlin; S Advani; Steven Allen; J Goldman; D Snyder; A Foti; M Cline
The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia.
The Journal of clinical investigation 1991;87(6):2042-7.
1991: A Foti; H G Ahuja; Steven Allen; Prasad R K Koduru; M W Schuster; Philip Schulman; M Bar-Eli; M J Cline
Correlation between molecular and clinical events in the evolution of chronic myelocytic leukemia to blast crisis.
Blood 1991;77(11):2441-4.
1991: Prasad R K Koduru; J C Goh; Steven Allen; L Karp; H Jasti; L C DeMarco; Stuart M Lichtman
Different patterns of chromosome and molecular breakage in classic Ph1 chronic myelogenous leukemia (CML) and variant Ph1 CML.
Hematologic pathology 1991;5(2):57-66.
1990: L Weiselberg; U Matulonis; E McGarvey; B Roberts; Stuart M Lichtman; Steven Allen; Vincent P Vinciguerra; Saul Teichberg
Stereologic analysis of monocytes and their subcellular organelles in patients with acute monocytic and myelomonocytic leukemia.
Laboratory investigation; a journal of technical methods and pathology 1990;63(3):405-12.
1990: Daniel R Budman; Willi Kreis; J Behr; Philip Schulman; Stuart M Lichtman; Steven Allen; L Weiselberg; W G Satterlee; R L Nelson; Vincent P Vinciguerra
Phase I trial of intravenous vinzolidine (LY 104208) given on a biweekly dosing schedule.
Investigational new drugs 1990;8(3):269-74.
1990: Steven Allen; M Coleman
Aggressive phase multiple myeloma: a terminal anaplastic transformation resembling high-grade lymphoma.
Cancer investigation 1990;8(3-4):417-24.
1989: Z M Sthoeger; M Wakai; D B Tse; Vincent P Vinciguerra; Steven Allen; Daniel R Budman; Stuart M Lichtman; Philip Schulman; L R Weiselberg; Nicholas Chiorazzi
Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia.
The Journal of experimental medicine 1989;169(1):255-68.
1988: Willi Kreis; C Rottach; Daniel R Budman; K Chan; Philip Schulman; Steven Allen; L Weiselberg; Vincent P Vinciguerra
Pharmacokinetic and phase I evaluation of esorubicin (4'-deoxydoxorubicin) by continuous infusion over forty-eight hours in patients with leukemia.
Cancer research 1988;48(19):5580-4.
1988: I Zanzi; S Taylor; E Gould; Steven Allen; S Kroop; S Asnis; D Margouleff
Scintigraphic and magnetic resonance studies in a patient with Gaucher's disease.
Clinical nuclear medicine 1988;13(7):491-5.
1988: Stuart M Lichtman; Philip Schulman; N Kardon; Steven Allen; M Susin
Monosomy 5 in acute megakaryoblastic leukemia. Report of two cases.
Cancer genetics and cytogenetics 1988;33(1):111-7.
1988: Willi Kreis; K Chan; Daniel R Budman; Philip Schulman; Steven Allen; L Weiselberg; Stuart M Lichtman; V Henderson; J Freeman; M Deere
Effect of tetrahydrouridine on the clinical pharmacology of 1-beta-D-arabinofuranosylcytosine when both drugs are coinfused over three hours.
Cancer research 1988;48(5):1337-42.
1988: Tsieh Sun; M Ngu; J Henshall; J Cuomo; A Eisenberg; P Benn; Steven Allen
Marker discrepancy as a diagnostic criterion for lymphoid neoplasms.
Diagnostic and clinical immunology 1988;5(6):393-9.
1987: Mark H Kaplan; M Susin; Savita Pahwa; J Fetten; Steven Allen; Stuart M Lichtman; M G Sarngadharan; Robert C Gallo
Neoplastic complications of HTLV-III infection. Lymphomas and solid tumors.
The American journal of medicine 1987;82(3):389-96.
1985: Willi Kreis; F Chaudhri; K Chan; Steven Allen; Daniel R Budman; Philip Schulman; L Weiselberg; J Freeman; M Deere; Vincent P Vinciguerra
Pharmacokinetics of low-dose 1-beta-D-arabinofuranosylcytosine given by continuous intravenous infusion over twenty-one days.
Cancer research 1985;45(12 Pt 1):6498-501.
1985: Steven Allen; M Coleman
Terminal-phase chronic myelogenous leukemia: approaches to treatment.
Cancer investigation 1985;3(5):491-503.
1982: J Laurence; M Coleman; Steven Allen; R T Silver; M Pasmantier
Combination chemotherapy of advanced diffuse histiocytic lymphoma with the six-drug COP-BLAM regimen.
Annals of internal medicine 1982;97(2):190-5.